- Home
- PSN vs QGEN Comparison
PSN vs QGEN Comparison
Compare PSN & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSN
- QGEN
- Stock Information
- Founded
- PSN 1944
- QGEN 1986
- Country
- PSN United States
- QGEN Netherlands
- Employees
- PSN N/A
- QGEN N/A
- Industry
- PSN EDP Services
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PSN Technology
- QGEN Health Care
- Exchange
- PSN Nasdaq
- QGEN Nasdaq
- Market Cap
- PSN 7.8B
- QGEN 9.1B
- IPO Year
- PSN 2019
- QGEN 1996
- Fundamental
- Price
- PSN $64.09
- QGEN $41.86
- Analyst Decision
- PSN Buy
- QGEN Buy
- Analyst Count
- PSN 11
- QGEN 8
- Target Price
- PSN $87.44
- QGEN $50.53
- AVG Volume (30 Days)
- PSN 1.4M
- QGEN 1.3M
- Earning Date
- PSN 04-30-2025
- QGEN 05-07-2025
- Dividend Yield
- PSN N/A
- QGEN 3.15%
- EPS Growth
- PSN 50.29
- QGEN N/A
- EPS
- PSN 2.35
- QGEN 0.42
- Revenue
- PSN $6,769,260,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- PSN $7.10
- QGEN $4.89
- Revenue Next Year
- PSN $5.88
- QGEN $6.41
- P/E Ratio
- PSN $27.20
- QGEN $100.26
- Revenue Growth
- PSN 16.61
- QGEN 3.31
- 52 Week Low
- PSN $54.56
- QGEN $37.63
- 52 Week High
- PSN $114.68
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- PSN 50.74
- QGEN 50.87
- Support Level
- PSN $60.09
- QGEN $42.04
- Resistance Level
- PSN $64.62
- QGEN $43.46
- Average True Range (ATR)
- PSN 2.16
- QGEN 0.83
- MACD
- PSN -0.31
- QGEN -0.10
- Stochastic Oscillator
- PSN 36.35
- QGEN 17.95
About PSN Parsons Corporation
Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).